3B Blackbio DX Ltd Nine Monthly Results

Gross Sales

73.97

51.13

43.73

62.25

207.86

Excise Duty

0

0

0

0

0

Net Sales

73.97

51.13

43.73

62.25

207.86

Other Operating Income

0

0

0

0

0

Other Income

10.14

8.34

6.07

5.03

1.7

Total Income

84.11

59.46

49.8

67.28

209.56

Total Expenditure

31.78

28.03

22.04

31.06

66.38

PBIDT

52.33

31.44

27.76

36.22

143.18

Interest

0.06

0.08

0.15

0.13

0.19

PBDT

52.26

31.36

27.6

36.09

143

Depreciation

0.81

0.75

0.66

0.5

0.51

Minority Interest Before NP

0

0

0

0

0

Tax

11.8

7.29

6.21

8.21

35.72

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

39.66

23.31

20.74

27.37

106.77

Minority Interest After NP

0.4

-0.55

2.6

3.32

13.17

Net Profit after Minority Interest

39.25

23.86

18.14

24.05

93.6

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

39.25

23.86

18.14

24.05

93.6

EPS (Unit Curr.)

46.28

27.21

24.21

36.46

142.2

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

8.57

8.57

8.57

7.51

7.51

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

70.74

61.49

63.48

58.18

68.88

PBDTM(%)

70.65

61.33

63.11

57.97

68.79

PATM(%)

53.61

45.58

47.42

43.96

51.36